CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases

Autor: Concha Ortiz-Cartagena, Daniel Pablo-Marcos, Laura Fernández-García, Lucía Blasco, Olga Pacios, Inés Bleriot, María Siller, María López, Javier Fernández, Belén Aracil, Pablo Arturo Fraile-Ribot, Sergio García-Fernández, Felipe Fernández-Cuenca, Marta Hernández-García, Rafael Cantón, Jorge Calvo-Montes, María Tomás

Publikováno v: Microbiology Spectrum, Vol 11, Iss 4 (2023)

ABSTRACT Carbapenem-resistant pathogens have been recognized as a health concern as they are both difficult to treat and detect in clinical microbiology laboratories. Researchers are making great efforts to develop highly specific, sensitive, accurat

Externí odkaz: https://doaj.org/article/84bc09a95f104ef695408a888a0ea7d7

Outbreak of Arcobacter butzleri? An emerging enteropathogen

Autor: Carlos Ruiz de Alegría Puig, Marta Fernández Martínez, Daniel Pablo Marcos, Jesús Agüero Balbín, Jorge Calvo Montes

Publikováno v: Enfermedades Infecciosas y Microbiología Clínica. 41:169-172

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08377cd1a8726a74600baac7570bb46c
https://doi.org/10.1016/j.eimc.2021.10.010

In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides

Autor: Silvia Velasco de la Fuente, Marta Fernández-Martinez, Jesús Rodríguez Lozano, Daniel Pablo-Marcos, María Siller, Jorge Calvo

Publikováno v: Enfermedades Infecciosas y Microbiología Clínica.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cd98bb11cb35f365441b11a4154eb41
https://doi.org/10.1016/j.eimc.2022.06.011

Persistencia orofaríngea de SARS-CoV-2: Influencia de la carga viral

Autor: Nuria Puente, Marina Fayos, Daniel Pablo-Marcos, Carmen Valero Díaz de Lamadrid

Publikováno v: Medicina Clinica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb3dd1552cc49289534b1a17ced077f5
http://europepmc.org/articles/PMC8590488

The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections

Autor: Rihard Trebše, Natalie Gassmann, Jaime Esteban, Benito Natividad, Bernhard Jost, Philipp Jent, Carol Strahm, Christine Thurnheer, Stéphane Corvec, Parham Sendi, Jaime Lora-Tamayo, Isabelle Waldmann, Tobias Kramer, Dorsaf Slama, Philippe Morand, Daniel Pablo-Marcos, Vincent A Stadelmann, Marta Fernandez-Sampedro, Yvonne Achermann, Robin Patel, Matteo Ferrari, Marjan Wouthuyzen-Bakker, Katharina Kusejko, Roger D. Kouyos, Giulia Scanferla, Ilker Uçkay, Martin Clauss, Prakhar Vijayvargiya, Álvaro Auñón

Publikováno v: Achermann, Yvonne; Kusejko, Katharina; Auñón, Álvaro; Clauss, Martin; Corvec, Stéphane; Esteban, Jaime; Fernandez-Sampedro, Marta; Ferrari, Matteo Carlo; Gassmann, Natalie; Jent, Philipp; Jost, Bernhard; Kouyos, Roger D; Kramer, Tobias Siegfried; Lora-Tamayo, Jaime; Morand, Philippe C; Benito, Natividad; Pablo-Marcos, Daniel; Patel, Robin; Scanferla, Giulia; Sendi, Parham; ... (2021). The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections. Clinical infectious diseases, 72(12), e1064-e1073. Oxford University Press 10.1093/cid/ciaa1839
Clinical Infectious Diseases, 72(12), E1064-E1073. Oxford University Press
Clin Infect Dis

Background Cutibacterium species are common pathogens in periprosthetic joint infections (PJI). These infections are often treated with β-lactams or clindamycin as monotherapy, or in combination with rifampin. Clinical evidence supporting the value

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26aaa37d0a8664b74ce69c9005519337
https://boris.unibe.ch/150566/1/Unbenannt.pdf